23andMe is exploring strategic alternatives, looking to raise capital
23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year. 23andMe said it will "need additional liquidity" to fund its operations, and it is looking to raise additional capital.
Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review
Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “
Veradigm ends exploration of strategic alternatives without deal
Veradigm (MDRX) announced that its board of directors completed its previously announced review of strategic alternatives. “Throughout the
NGVT to Evaluate Strategic Alternatives for Industrial Specialties
Ingevity Corporation NGVT recently announced plans to explore strategic alternatives for its Performance Chemicals Industrial Specialties product line, including a potential divestiture of a portion of the company’s North Charleston site.
Genetic test maker 23andMe eyes strategic alternatives, including a sale
Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said Tuesday, months after co-founder and CEO Anne Wojcicki's buyout plan started a fight with her onetime board.
23andMe announces exploration of strategic alternatives
The Special Committee of the board of 23andMe Holding Co. announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a poss
23andMe says it's exploring alternatives, including a sale
Genetic testing firm 23andMe (NASDAQ:ME) said it formed a special board committee to review strategic alternatives. The special committee will look at options including a sale, business combination, licensing of assets,
Sage rejects Biogen’s buyout offer, but says it's open to deals
Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...
aasa.org11d
Rethinking Strategic Planning: Three Inspiring Alternatives to an Outdated Process
In this session, superintendents are introduced to an annual process for establishing a more dynamic approach to strategy.
Morningstar7d
Strategic Advisers Alternatives FSLTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
FiercePharma5d
No deal: Sage rejects Biogen's buyout offer, scouts for strategic alternatives
After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...
Hosted on MSN19d
S&W Seed rises after starting review of strategic alternatives
S &W Seed (NASDAQ:SANW) +4.8% post-market Monday after saying its board has launched a process to explore and evaluate various strategic alternatives, including a sale of the company, a merger ...
BioSpace5d
Sage Rejects Biogen’s Unsolicited Offer, Will Seek Strategic Alternatives
Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the ...